These findings offer a solid basis for designing clinical trials of therapies aimed at modifying the development of these neurodegenerative diseases by acting against α-synuclein.
Read moreLos avances en genética están impulsando mejores diagnósticos, así como el desarrollo de tratamientos más personalizados para los pacientes con tumores de cáncer de páncreas con mutaciones espe...
Read moreThree research institutions in Barcelona have teamed up to launch the world’s first Joint Program on Evolutionary Medical Genomics.
Read moreLet’s look at the most noteworthy news from November, showcasing the vibrancy and constant innovation in the BioRegion of Catalonia, from basic research to clinical applications and international bu...
Read moreThe main objective is to demonstrate that this technology not only generates benefits for the patient, but also reduces time and saves resources in the medical center
Read moreHan demostrado en pacientes afectados por el subtipo A de la anemia de Fanconi (causado por mutaciones en el gen FANCA) que incluso en ausencia de acondicionamiento con quimioterapia, la autotransfusi...
Read moreLos resultados muestran que la terapia ha corregido un mecanismo de comunicación neuronal alterado en la enfermedad y ha mejorado la capacidad de movimiento y de aprendizaje de los ratones con SPG52
Read moreNRTX-1001 has been well-tolerated to date at both high and low doses. No adverse events have been attributed to the cell therapy
Read moreConsuming 20-30% of daily energy intake in the morning influences key cardiovascular risk factors. People who consume the right amount of energy in the morning have 2-3.5% lower body mass index, less ...
Read moreMinoryx Therapeutics, a late-stage biotech company focused on the development of therapies for orphan central nervous system (CNS) disorders and Neuraxpharm Group (Neuraxpharm), a leading European spe...
Read moreSB-007 is the only IND-cleared, clinical-stage therapeutic addressing the root cause of Stargardt disease with the potential to treat all patients across all ABCA4 mutations
Read moreA team from the Clínic-IDIBAPS, the Institute of Neurosciences UBNeuro and the University of Barcelona led by Yaroslau Compta has participated in an international study where an update of the seed am...
Read more